Investigation of Peptidoglycan-Associated Lipoprotein of <i>Acinetobacter baumannii</i> and Its Interaction with Fibronectin To Find Its Therapeutic Potential-Reference-Cited by-同舟云学术

Investigation of Peptidoglycan-Associated Lipoprotein of Acinetobacter baumannii and Its Interaction with Fibronectin To Find Its Therapeutic Potential

Published:2023-05-16 Issue:5 Volume:91 Page:
ISSN:0019-9567
Container-title:Infection and Immunity
language:en
Short-container-title:Infect Immun

Author:

Solanki Vandana¹,Tiwari Monalisa¹,Tiwari Vishvanath¹^ORCID

Affiliation:

1. Department of Biochemistry, Central University of Rajasthan, Ajmer, Rajasthan, India

Abstract

Acinetobacter baumannii causes hospital-acquired infections and is responsible for high mortality and morbidity. The interaction of this bacterium with the host is critical in bacterial pathogenesis and infection.

Funder

DST | Science and Engineering Research Board

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Immunology,Microbiology,Parasitology

Link

https://journals.asm.org/doi/pdf/10.1128/iai.00023-23

Reference121 articles.

1. Acinetobacter baumannii Antibiotic Resistance Mechanisms

2. Potentiate the activity of current antibiotics by naringin dihydrochalcone targeting the AdeABC efflux pump of multidrug-resistant Acinetobacter baumannii

3. Targeting Outer Membrane Protein Component AdeC for the Discovery of Efflux Pump Inhibitor against AdeABC Efflux Pump of Multidrug Resistant Acinetobacter baumannii